Thornburg Investment Management Inc. Boosts Stake in Fresenius Medical Care AG & Co. (FMS)

Thornburg Investment Management Inc. grew its holdings in shares of Fresenius Medical Care AG & Co. (NYSE:FMS) by 11.6% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 482,187 shares of the company’s stock after purchasing an additional 49,941 shares during the period. Thornburg Investment Management Inc.’s holdings in Fresenius Medical Care AG & Co. were worth $24,794,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also bought and sold shares of the company. Acadian Asset Management LLC bought a new position in shares of Fresenius Medical Care AG & Co. during the 2nd quarter valued at about $106,000. Destination Wealth Management bought a new position in shares of Fresenius Medical Care AG & Co. during the 2nd quarter valued at about $158,000. Mount Yale Investment Advisors LLC bought a new position in shares of Fresenius Medical Care AG & Co. during the 2nd quarter valued at about $192,000. Intercontinental Wealth Advisors LLC bought a new position in shares of Fresenius Medical Care AG & Co. during the 2nd quarter valued at about $203,000. Finally, Cibc Bank USA bought a new position in shares of Fresenius Medical Care AG & Co. during the 3rd quarter valued at about $215,000. Institutional investors own 2.46% of the company’s stock.

Shares of FMS traded up $3.37 during midday trading on Wednesday, hitting $43.03. The stock had a trading volume of 700 shares, compared to its average volume of 280,664. Fresenius Medical Care AG & Co. has a fifty-two week low of $38.43 and a fifty-two week high of $57.94. The stock has a market cap of $23.63 billion, a price-to-earnings ratio of 17.95, a PEG ratio of 1.71 and a beta of 1.10. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.24 and a quick ratio of 1.00.

Several brokerages have commented on FMS. Zacks Investment Research upgraded shares of Fresenius Medical Care AG & Co. from a “sell” rating to a “hold” rating in a report on Thursday, August 30th. HSBC upgraded shares of Fresenius Medical Care AG & Co. from a “hold” rating to a “buy” rating in a report on Tuesday, August 28th. Royal Bank of Canada reiterated a “neutral” rating on shares of Fresenius Medical Care AG & Co. in a report on Wednesday, October 17th. DZ Bank reiterated a “buy” rating on shares of Fresenius Medical Care AG & Co. in a report on Monday, August 6th. Finally, ValuEngine cut shares of Fresenius Medical Care AG & Co. from a “hold” rating to a “sell” rating in a report on Wednesday, October 17th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and six have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average price target of $67.33.

TRADEMARK VIOLATION NOTICE: This article was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this article on another domain, it was illegally stolen and reposted in violation of international copyright law. The original version of this article can be read at https://www.dispatchtribunal.com/2018/11/07/thornburg-investment-management-inc-boosts-stake-in-fresenius-medical-care-ag-co-fms.html.

Fresenius Medical Care AG & Co. Company Profile

Fresenius Medical Care AG & Co KGaA provides products and services for patients with chronic kidney failure. The company’s products include dialysis machines, dialyzers and related disposables. It also offers renal information technology solutions and provides services such as renal replacement therapy and therapeutic apheresis.

Featured Article: Compound Annual Growth Rate (CAGR)

Want to see what other hedge funds are holding FMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Fresenius Medical Care AG & Co. (NYSE:FMS).

Institutional Ownership by Quarter for Fresenius Medical Care AG & Co. (NYSE:FMS)

Receive News & Ratings for Fresenius Medical Care AG & Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply